A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Clinical trial NCT05570253 · RECRUITING
Trial details
- NCT number
- NCT05570253
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-03
- Primary completion
- 2027-10-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.